Abstract
Rheumatoid arthritis and lupus belong to a number of autoimmune diseases
affecting the musculoskeletal system, multisystemic tissue, and connective
tissues. Although a range of autoimmune conditions carry a low prevalence,
combined these diseases amount to a growing medical and economic burden.
Additionally, autoimmune diseases are accounting for a growing cause of
disability in the United States, Europe and worldwide.
Kalorama' s Worldwide Market for Rheumatoid Arthritis and Lupus Treatments
(Autoimmune Disease Markets) is the most comprehensive look at the markets for
treatments for these two important diseases in the autoimmune disorder
category: rheumatoid arthritis and lupus. As part of its thorough, ground up
research-- the product of interviews with market experts conducted by an
experienced pharmaceutical market analyst, this report includes:
- Market Size and Forecast for NSAIDs and Biologic Treatments
- New Products in Development
- Important Issues and Trends
- Company Profiles
- Market Share
- Regional Revenues Breakout
Product Managers, marketing managers, business development executives and
investment professionals are among those who will find this report to be a
useful resource.
View Cart
